Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
222 Increased PD-L1 tumor expression correlates with high rate of response to PD-1 inhibitors in patients with unresectable, recurrent, and metastatic cutaneous squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
